Key result
CFTR c.1666A>G mutation strongly linked to the causative gene for Hereditary Inclusion Body Myopathy.
Why the study?
The candidate gene responsible for the phenotype in Hereditary Inclusion Body Myopathy (HIBM) pedigree was unknown and needed identification.
Observational (n=117)
Answers are grounded in this paper and cite their sources.
The CFTR c.1666A>G mutation may be a candidate marker with strong genetic linkage to the causative gene in Hereditary Inclusion Body Myopathy.
Hereditary Inclusion Body Myopathy (HIBM) is a rare autosomal dominant or recessive adult onset muscle disease which affects one to three individuals per million worldwide. This disease is autosomal dominant or recessive [corrected] and occurs in adulthood. Our previous study reported a new subtype of HIBM linked to the susceptibility locus at 7q22.1-31.1. The present study is aimed to identify the candidate gene responsible for the phenotype in HIBM pedigree. After multipoint linkage analysis, we performed targeted capture sequencing on 16 members and whole-exome sequencing (WES) on 5 members. Bioinformatics filtering was performed to prioritize the candidate pathogenic gene variants, which were further genotyped by Sanger sequencing. Our results showed that the highest peak of LOD score (4.70) was on chromosome 7q22.1-31.1.We identified 2 and 22 candidates using targeted capture sequencing and WES respectively, only one of which as CFTRc.1666A>G mutation was well cosegregated with the HIBM phenotype. Using transcriptome analysis, we did not detect the differences of CFTR's mRNA expression in the proband compared with healthy members. Due to low incidence of HIBM and there is no other pedigree to assess, mutation was detected in three patients with duchenne muscular dystrophyn (DMD) and five patients with limb-girdle muscular dystrophy (LGMD). And we found that the frequency of mutation detected in DMD and LGMD patients was higher than that of being expected in normal population. We suggested that the CFTRc.1666A>G may be a candidate marker which has strong genetic linkage with the causative gene in the HIBM family.
No takes yet. Share an insight, caveat, or question.
Lü et al. (2018) conducted an observational in Hereditary Inclusion Body Myopathy (HIBM) (n=117). CFTR c.1666A>G mutation vs. Wild type / healthy individuals was evaluated on Identification of candidate pathogenic gene variants co-segregating with HIBM phenotype. The CFTR c.1666A>G mutation was identified as a candidate marker with strong genetic linkage to the causative gene in a Hereditary Inclusion Body Myopathy family, with a maximum LOD score of 4.70 on chromosome 7q22.1-31.1.
Synapse has enriched 10 related papers. Consider them for comparative context: